This really is one of those great shames of the US. Insulin is 10x what it should cost. Out of pocket, Fiasp costs 7.50 euro per 3ml, Novorapid costs 6.50, Nov

This really is one of those great shames of the US. Insulin is 10x what it should cost. Out of pocket, Fiasp costs 7.50 euro per 3ml, Novorapid costs 6.50, Novomix 30 is 7 euro, Triseba 12 euro, even the ridiculously pricy Xultophy is only 30 euro. The idea that "We halved the price" when the price is literally ten times too high, and not presenting it as "a start, we intend to bring the price down far more over the next few years" but as "and then we stopped, we're undercutting and that's all we're interested in" is... insane?